IART · Integra Lifesciences Holdings Corp
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-07-29 |
Integra LifeSciences Reports Second Quarter 2026 Financial Results
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026. Second Quarter 2026 Highlights Second quarter revenues of $418.8 |
| 2026-07-16 |
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. In conjunction with the earnings |
| 2026-07-02 |
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. PRINCETON, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today |
| 2026-06-23 |
Integra LifeSciences Announces Key Executive Appointments
Leadership appointments reinforce company’s commitment to enhancing commercial execution and deepening customer engagement, while building leadership depth PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical |
| 2026-06-15 |
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice president and president Tissue Reconstruction will present at the 2026 Truist Securities MedTech |
| 2026-06-02 |
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at |
| 2026-05-08 |
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm |
| 2026-05-05 |
Integra LifeSciences Reports First Quarter 2026 Financial Results
PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026. First Quarter 2026 Highlights First quarter revenues of $391.9 |
| 2026-05-05 |
Integra LifeSciences Announces Leadership Transition
Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART), a leading global medical |
| 2026-04-20 |
Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026
PRINCETON, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2026 financial results on Tuesday, May 5, 2026, prior to the market open. In conjunction with the earnings release, |
| 2026-04-07 |
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization
Results to be featured at Functional Diabetic Limb Salvage, Society of Advanced Wound Care and American Burn Association Conferences in April PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, |
| 2026-02-26 |
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Reported revenues were $434.9 million, representing a decrease of 1.7% on |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-29 | Integra LifeSciences Q2’2026 Earnings Call | Earnings call |
| 2026-06-16 | Truist Securities MedTech Conference | Conference |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-12 | BofA Securities 2026 Healthcare Conference | Conference |
| 2026-05-05 | Integra LifeSciences Q1’2026 Earnings Call | Earnings call |
| 2026-03-16 | Wells Fargo innovation Spotlight Series featuring Ray Turner Chief Medical Officer | Event |
| 2026-02-26 | Integra LifeSciences Q4’2025 Earnings Call | Earnings call |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-03 | Citi 2025 Global Healthcare Conference | Conference |
| 2025-10-30 | Integra LifeSciences Q3’2025 Earnings Call | Earnings call |
| 2025-09-10 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |